Revenue from Pharmaceutical Drug Sales: $33.27 billion
Total Revenue: $33.27 billion
Percent of Revenue From Pharmaceutical Drug Sales: 100%
Estimated R&D Spend: $6.40 billion
Number of Employees: 30,000
Revenue Per Employee: $1,100,000
AbbVie is an American biopharmaceutical company formed in 2013 and was formed when Abbott Laboratories announced its plan to separate into two publicly traded companies. It was decided that the “new” Abbott Laboratories would specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie would operate as a research-based pharmaceutical manufacturer that specialises in making small molecule drugs for patients worldwide.
The company focuses on therapy areas such as dermatology, oncology, neurological disorders and metabolic diseases.
AbbVie’s most well known for its rheumatoid arthritis med Humira (Humira makes up more than 60% of AbbVie’s total sales) along with Imbruvica, Lupron, Veikira and Synthroid.
Ref: AbbVie Inc Annual Report 2019